LAMP1 and neoplasm: When we evaluated the expression of the three markers, depending on the tumor stage, the data showed that LAMP1 had a tendency to decrease with advancing stage, while Giantin was clearly increasing with a more advanced stage, although none of the trends attended statistical significance, probably due to the low number of cases available here (Figure 9A).